The Swiss Times - Swiss News in English

700 Deaths Due to Side Effects Per Year in Switzerland

In Switzerland, between 2012 and 2019, an average of 32,000 people were admitted to hospital each year due to side effects of medication. This is the first time this has been revealed by a joint study conducted by the universities of Lucerne and Zurich, the University Hospital Zurich and Swissmedic. Despite the legal requirement to report, only around 5% of these cases were reported to the Swissmedic medicines agency, according to the University of Lucerne (Unilu). These reports are very important, according to the study leader Patrick Beeler, as they are the main foundation for drug safety and most of the previously unknown risks can be discovered this way. Beeler advocates for the reporting requirement to be adequately addressed in the training of medical professionals. Internationally, this reporting rate is high, according to Beeler. Internationally, the reporting rate is estimated to be between 0.6 and 4.7%. Side effects of medication were responsible for 2.3% of all hospital admissions during the 8-year study period. Almost half of those admitted due to side effects (46.9%) were over 65 years old. The most common side effects observed were related to the digestive system (such as gastric inflammation), the urogenital system (such as acute renal failure) or mental/behavioral state (such as opioid dependence). 2.2% of those admitted due to side effects, or around 700 per year, died in hospital, according to the study. Of these deaths, around 12% were reported to Swissmedic.

©Keystone/SDA

Most Read

Delivery Services in Switzerland Have New Competition

22 February 2024
Delivery service
An Austrian company opens it's first online supermarket outside the country. Targeting the greater Zurich area.

Murder in Frauenfeld: Trial for the Murder of an Egyptian

22 February 2024
Murder in Frauenfeld
Two men face murder charges over the 2007 killing of a 27-year-old Egyptian, whose body was discovered submerged in Barchetsee.

Swiss Semi-Conductor Government Initiative: Will it Work?

23 February 2024
Swiss semiconductor
SwissChips Initiative represents Switzerland's strategic move to bolster its semiconductor industry amidst global competition.

Swiss CEO Vranckx Moves to the Lufthansa Executive Board

23 February 2024
Swiss CEO
Swiss CEO Dieter Vranckx moves to Lufthansa as Chief Commercial Officer, after leading Swiss through challenging times.

Stay in Touch!

Noteworthy

Swiss biotech
Swiss Biotech Firm Idorsia: Stock Soars – but Why?
26 February 2024
Decathlon
Decathlon Opens 5 more Stores in Switzerland
26 February 2024